{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:28:19Z","timestamp":1770834499938,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-1137302B, TCVGH-1135003B and TCVGH-1143903B"],"award-info":[{"award-number":["TCVGH-1137302B, TCVGH-1135003B and TCVGH-1143903B"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-1137302B, TCVGH-1135003B and TCVGH-1143903B"],"award-info":[{"award-number":["TCVGH-1137302B, TCVGH-1135003B and TCVGH-1143903B"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2314-B-075A-005"],"award-info":[{"award-number":["NSTC 113-2314-B-075A-005"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"DOI":"10.1186\/s40959-026-00445-7","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T11:46:22Z","timestamp":1768563982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between polygenic risk scores and cardiovascular events in prostate cancer patients receiving androgen deprivation therapy in Han Chinese"],"prefix":"10.1186","volume":"12","author":[{"given":"Qun\u2011Yi","family":"Nian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Wen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Ri","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Chun","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Chieh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"issue":"4","key":"445_CR1","first-page":"293","volume":"1","author":"C Huggins","year":"1941","unstructured":"Huggins C, Hodges CV. Studies on prostatic cancer. I. The effect of castration, of Estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1941;1(4):293\u20137.","journal-title":"Cancer Res"},{"issue":"1","key":"445_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/JU.0000000000001375","volume":"205","author":"WT Lowrance","year":"2021","unstructured":"Lowrance WT, Breau RH, Chou R, Chapin BF, Crispino T, Dreicer R, et al. Advanced prostate cancer: AUA\/ASTRO\/SUO guideline part I. J Urol. 2021;205(1):14\u201321.","journal-title":"J Urol"},{"issue":"8","key":"445_CR3","doi-asserted-by":"publisher","first-page":"e2119568","DOI":"10.1001\/jamanetworkopen.2021.19568","volume":"4","author":"AO Elmehrath","year":"2021","unstructured":"Elmehrath AO, Afifi AM, Al-Husseini MJ, Saad AM, Wilson N, Shohdy KS, et al. Causes of death among patients with metastatic prostate cancer in the US from 2000 to 2016. JAMA Netw Open. 2021;4(8):e2119568\u2013e.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"445_CR4","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/j.1464-410X.2007.07184.x","volume":"100","author":"IH Derweesh","year":"2007","unstructured":"Derweesh IH, DiBlasio CJ, Kincade MC, Malcolm JB, Lamar KD, Patterson AL, et al. Risk of new-onset diabetes mellitus and worsening glycaemic variables for established diabetes in men undergoing androgen\u2010deprivation therapy for prostate cancer. BJU Int. 2007;100(5):1060\u20135.","journal-title":"BJU Int"},{"issue":"5","key":"445_CR5","first-page":"761","volume":"6","author":"DP Leong","year":"2024","unstructured":"Leong DP, Fradet V, Niazi T, Selvanayagam JB, Sabbagh R, Higano CS, et al. Adiposity and muscle strength in men with prostate cancer and cardiovascular outcomes. Cardio Oncol. 2024;6(5):761\u201371.","journal-title":"Cardio Oncol"},{"issue":"1","key":"445_CR6","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1186\/s12872-024-04421-w","volume":"24","author":"AA Khorram","year":"2024","unstructured":"Khorram AA, Pourasgharian R, Shams AS, Toufani S, Mostafaei M, Khademi R, et al. Androgen deprivation therapy use and the risk of heart failure in patients with prostate cancer: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2024;24(1):756.","journal-title":"BMC Cardiovasc Disord"},{"issue":"7","key":"445_CR7","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/ijc.34058","volume":"151","author":"RB Forster","year":"2022","unstructured":"Forster RB, Engeland A, Kv\u00e5le R, Hjellvik V, Bj\u00f8rge T. Association between medical androgen deprivation therapy and long-term cardiovascular disease and all\u2010cause mortality in nonmetastatic prostate cancer. Int J Cancer. 2022;151(7):1109\u201319.","journal-title":"Int J Cancer"},{"issue":"12","key":"445_CR8","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1038\/s41416-023-02271-5","volume":"128","author":"JSK Chan","year":"2023","unstructured":"Chan JSK, Satti DI, Lee YHA, Hui JMH, Dee EC, Ng K, et al. Temporal trends in cardiovascular burden among patients with prostate cancer receiving androgen deprivation therapy: a population-based cohort study. Br J Cancer. 2023;128(12):2253\u201360.","journal-title":"Br J Cancer"},{"issue":"4","key":"445_CR9","first-page":"340","volume":"16","author":"X Wang","year":"2023","unstructured":"Wang X, Khurshid S, Choi SH, Friedman S, Weng L-C, Reeder C, et al. Genetic susceptibility to atrial fibrillation identified via deep learning of 12-lead electrocardiograms. Circulation: Genomic Precision Med. 2023;16(4):340\u20139.","journal-title":"Circulation: Genomic Precision Med"},{"issue":"9","key":"445_CR10","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.hrthm.2024.03.1817","volume":"21","author":"CI Wu","year":"2024","unstructured":"Wu CI, Chen IC, Chen YY, Chen YM, Lin YJ, Hsieh YC, et al. Susceptibility of atrial fibrillation in genetic architecture and heritability: A genome-wide association study in Taiwan. Heart Rhythm. 2024;21(9):1656\u20137. https:\/\/doi.org\/10.1016\/j.hrthm.2024.03.1817. Epub 20240402.","journal-title":"Heart Rhythm"},{"issue":"1","key":"445_CR11","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1038\/s41467-023-39253-3","volume":"14","author":"D Rasooly","year":"2023","unstructured":"Rasooly D, Peloso GM, Pereira AC, Dashti H, Giambartolomei C, Wheeler E, et al. Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failure. Nat Commun. 2023;14(1):3826.","journal-title":"Nat Commun"},{"issue":"6","key":"445_CR12","first-page":"e003452","volume":"14","author":"HD Manikpurage","year":"2021","unstructured":"Manikpurage HD, Eslami A, Perrot N, Li Z, Couture C, Mathieu P, et al. Polygenic risk score for coronary artery disease improves the prediction of early-onset myocardial infarction and mortality in men. Circulation: Genomic Precision Med. 2021;14(6):e003452.","journal-title":"Circulation: Genomic Precision Med"},{"issue":"7","key":"445_CR13","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1038\/s41591-023-02429-x","volume":"29","author":"AP Patel","year":"2023","unstructured":"Patel AP, Wang M, Ruan Y, Koyama S, Clarke SL, Yang X, et al. A multi-ancestry polygenic risk score improves risk prediction for coronary artery disease. Nat Med. 2023;29(7):1793\u2013803. https:\/\/doi.org\/10.1038\/s41591-023-02429-x.","journal-title":"Nat Med"},{"issue":"18","key":"445_CR14","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1093\/eurheartj\/ehac093","volume":"43","author":"X Lu","year":"2022","unstructured":"Lu X, Liu Z, Cui Q, Liu F, Li J, Niu X, et al. A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study. Eur Heart J. 2022;43(18):1702\u201311. https:\/\/doi.org\/10.1093\/eurheartj\/ehac093.","journal-title":"Eur Heart J"},{"issue":"11","key":"445_CR15","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/s41588-020-0705-3","volume":"52","author":"S Koyama","year":"2020","unstructured":"Koyama S, Ito K, Terao C, Akiyama M, Horikoshi M, Momozawa Y, et al. Population-specific and trans-ancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease. Nat Genet. 2020;52(11):1169\u201377. https:\/\/doi.org\/10.1038\/s41588-020-0705-3.","journal-title":"Nat Genet"},{"issue":"2","key":"445_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2217\/14622416.9.2.235","volume":"9","author":"C-T Fan","year":"2008","unstructured":"Fan C-T, Lin J-C, Lee C-H. Taiwan biobank: a project aiming to aid taiwan\u2019s transition into a biomedical Island. Pharmacogenomics. 2008;9(2):235\u201346.","journal-title":"Pharmacogenomics"},{"issue":"1","key":"445_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41525-021-00178-9","volume":"6","author":"C-Y Wei","year":"2021","unstructured":"Wei C-Y, Yang J-H, Yeh E-C, Tsai M-F, Kao H-J, Lo C-Z, et al. Genetic profiles of 103,106 individuals in the Taiwan biobank provide insights into the health and history of Han Chinese. NPJ Genomic Med. 2021;6(1):10.","journal-title":"NPJ Genomic Med"},{"issue":"10","key":"445_CR18","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.3656","volume":"48","author":"S Das","year":"2016","unstructured":"Das S, Forer L, Sch\u00f6nherr S, Sidore C, Locke AE, Kwong A, et al. Next-generation genotype imputation service and methods. Nat Genet. 2016;48(10):1284\u20137.","journal-title":"Nat Genet"},{"issue":"7571","key":"445_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"GP Consortium","year":"2015","unstructured":"Consortium GP. A global reference for human genetic variation. Nature. 2015;526(7571):68.","journal-title":"Nature"},{"issue":"2","key":"445_CR20","doi-asserted-by":"publisher","first-page":"e1608","DOI":"10.1002\/mpr.1608","volume":"27","author":"AT Marees","year":"2018","unstructured":"Marees AT, De Kluiver H, Stringer S, Vorspan F, Curis E, Marie-Claire C, et al. A tutorial on conducting genome\u2010wide association studies: quality control and statistical analysis. Int J Methods Psychiatr Res. 2018;27(2):e1608.","journal-title":"Int J Methods Psychiatr Res"},{"key":"445_CR21","doi-asserted-by":"publisher","unstructured":"Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4(1):s13742-015-0047-8. https:\/\/doi.org\/10.1186\/s13742-015-0047-8.","DOI":"10.1186\/s13742-015-0047-8"},{"issue":"6","key":"445_CR22","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.ajhg.2019.11.001","volume":"105","author":"F Priv\u00e9","year":"2019","unstructured":"Priv\u00e9 F, Vilhj\u00e1lmsson BJ, Aschard H, Blum MG. Making the most of clumping and thresholding for polygenic scores. Am J Hum Genet. 2019;105(6):1213\u201321.","journal-title":"Am J Hum Genet"},{"issue":"7934","key":"445_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-022-05165-3","volume":"611","author":"A Mishra","year":"2022","unstructured":"Mishra A, Malik R, Hachiya T, J\u00fcrgenson T, Namba S, Posner DC, et al. Stroke genetics informs drug discovery and risk prediction across ancestries. Nature. 2022;611(7934):115\u201323. https:\/\/doi.org\/10.1038\/s41586-022-05165-3.","journal-title":"Nature"},{"issue":"6","key":"445_CR24","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1161\/CIRCULATIONAHA.109.192695","volume":"121","author":"GN Levine","year":"2010","unstructured":"Levine GN, D\u2019Amico AV, Berger P, Clark PE, Eckel RH, Keating NL, et al. Androgen-Deprivation therapy in prostate cancer and cardiovascular risk. Circulation. 2010;121(6):833\u201340. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.192695.","journal-title":"Circulation"},{"key":"445_CR25","first-page":"129","volume":"7","author":"JF Lester","year":"2015","unstructured":"Lester JF, Mason MD. Cardiovascular effects of hormone therapy for prostate cancer. Drug Healthc Patient Saf. 2015;7:129\u201338. Epub 20150723. doi: 10.2147\/dhps.S50549. PubMed PMID: 26229507; PubMed Central PMCID: PMC4516188.","journal-title":"Drug Healthc Patient Saf"},{"issue":"8","key":"445_CR26","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/pros.24519","volume":"83","author":"CHM Wong","year":"2023","unstructured":"Wong CHM, Xu N, Lim J, Feng KK, Chan WKW, Chan MTY, et al. Adverse metabolic consequences of androgen deprivation therapy (ADT) on Asian patients with prostate cancer: primary results from the real-life experience of ADT in Asia (READT) study. Prostate. 2023;83(8):801\u20138. Epub 20230320. doi: 10.1002\/pros.24519. PubMed PMID: 36938957.","journal-title":"Prostate"},{"issue":"3","key":"445_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1530\/eje-16-0200","volume":"175","author":"AS Cheung","year":"2016","unstructured":"Cheung AS, Hoermann R, Dupuis P, Joon DL, Zajac JD, Grossmann M. Relationships between insulin resistance and frailty with body composition and testosterone in men undergoing androgen deprivation therapy for prostate cancer. Eur J Endocrinol. 2016;175(3):229\u201337. https:\/\/doi.org\/10.1530\/eje-16-0200. Epub 20160623.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"445_CR28","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1210\/jc.2005-2507","volume":"91","author":"MR Smith","year":"2006","unstructured":"Smith MR, Lee H, Nathan DM. Insulin sensitivity during combined androgen Blockade for prostate cancer. J Clin Endocrinol Metab. 2006;91(4):1305\u20138. https:\/\/doi.org\/10.1210\/jc.2005-2507. Epub 20060124.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6b","key":"445_CR29","doi-asserted-by":"publisher","first-page":"E82","DOI":"10.1111\/bju.12732","volume":"114","author":"G Gandaglia","year":"2014","unstructured":"Gandaglia G, Sun M, Popa I, Schiffmann J, Abdollah F, Trinh QD, et al. The impact of androgen-deprivation therapy (ADT) on the risk of cardiovascular (CV) events in patients with non-metastatic prostate cancer: a population-based study. BJU Int. 2014;114(6b):E82\u20139. https:\/\/doi.org\/10.1111\/bju.12732. Epub 20140727.","journal-title":"BJU Int"},{"issue":"8","key":"445_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11886-021-01561-9","volume":"23","author":"J Boland","year":"2021","unstructured":"Boland J, Choi W, Lee M, Lin J. Cardiovascular toxicity of androgen deprivation therapy. Curr Cardiol Rep. 2021;23(8):109. https:\/\/doi.org\/10.1007\/s11886-021-01561-9. Epub 20210703.","journal-title":"Curr Cardiol Rep"},{"issue":"2","key":"445_CR31","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.urology.2012.10.050","volume":"81","author":"N Hara","year":"2013","unstructured":"Hara N, Ishizaki F, Saito T, Nishiyama T, Kawasaki T, Takahashi K. Decrease in lean body mass in men with prostate cancer receiving androgen deprivation therapy: mechanism and biomarkers. Urology. 2013;81(2):376\u201380. https:\/\/doi.org\/10.1016\/j.urology.2012.10.050. PubMed PMID: 23374809.","journal-title":"Urology"},{"issue":"3","key":"445_CR32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2265.2010.03942.x","volume":"74","author":"E Hamilton","year":"2011","unstructured":"Hamilton E, Gianatti E, Strauss B, Wentworth J, Lim-Joon D, Bolton D, et al. Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy. Clin Endocrinol. 2011;74(3):377\u201383.","journal-title":"Clin Endocrinol"},{"issue":"2","key":"445_CR33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2265.2011.04189","volume":"76","author":"KB Rubinow","year":"2012","unstructured":"Rubinow KB, Snyder CN, Amory JK, Hoofnagle AN, Page ST. Acute testosterone deprivation reduces insulin sensitivity in men. Clin Endocrinol (Oxf). 2012;76(2):281\u20138. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04189. x. PubMed PMID: 21797916; PubMed Central PMCID: PMC3224202.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"445_CR34","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1161\/ATVBAHA.119.313046","volume":"40","author":"JR Hu","year":"2020","unstructured":"Hu JR, Duncan MS, Morgans AK, Brown JD, Meijers WC, Freiberg MS, et al. Cardiovascular effects of androgen deprivation therapy in prostate cancer: contemporary Meta-Analyses. Arterioscler Thromb Vasc Biol. 2020;40(3):e55\u201364. PubMed PMID: 31969015; PubMed Central PMCID: PMC7047549.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"445_CR35","doi-asserted-by":"publisher","unstructured":"Solanki AJ, Kamrava M, Posadas EM, Freedland SJ, Ballas L, Sandler HM et al. A practical guide for assessing and managing cardiovascular risk during androgen-deprivation therapy in patients with prostate cancer. Cancer. 2024. https:\/\/doi.org\/10.1002\/cncr.35285.","DOI":"10.1002\/cncr.35285"},{"issue":"5","key":"445_CR36","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","volume":"67","author":"PL Nguyen","year":"2015","unstructured":"Nguyen PL, Alibhai SM, Basaria S, D\u2019Amico AV, Kantoff PW, Keating NL, et al. Adverse effects of androgen deprivation therapy and strategies to mitigate them. Eur Urol. 2015;67(5):825\u201336.","journal-title":"Eur Urol"},{"issue":"4","key":"445_CR37","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/ijc.34557","volume":"153","author":"JSK Chan","year":"2023","unstructured":"Chan JSK, Lee YHA, Hui JMH, Liu K, Dee EC, Ng K, et al. Long-term prognostic impact of cardiovascular comorbidities in patients with prostate cancer receiving androgen deprivation therapy: A population-based competing risk analysis. Int J Cancer. 2023;153(4):756\u201364. https:\/\/doi.org\/10.1002\/ijc.34557. Epub 20230514.","journal-title":"Int J Cancer"},{"issue":"6","key":"445_CR38","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1073\/pnas.051003698","volume":"98","author":"L Nathan","year":"2001","unstructured":"Nathan L, Shi W, Dinh H, Mukherjee TK, Wang X, Lusis AJ, et al. Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase. Proc Natl Acad Sci U S A. 2001;98(6):3589\u201393. https:\/\/doi.org\/10.1073\/pnas.051003698. Epub 20010306.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"445_CR39","doi-asserted-by":"publisher","first-page":"5428","DOI":"10.1210\/en.2010-0663","volume":"151","author":"J Bourghardt","year":"2010","unstructured":"Bourghardt J, Wilhelmson AS, Alexanderson C, De Gendt K, Verhoeven G, Krettek A, et al. Androgen receptor-dependent and independent atheroprotection by testosterone in male mice. Endocrinology. 2010;151(11):5428\u201337. https:\/\/doi.org\/10.1210\/en.2010-0663. Epub 20100922.","journal-title":"Endocrinology"},{"issue":"5","key":"445_CR40","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/s0006-291x(02)02038-7","volume":"296","author":"C Langer","year":"2002","unstructured":"Langer C, Gansz B, Goepfert C, Engel T, Uehara Y, von Dehn G, et al. Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages. Biochem Biophys Res Commun. 2002;296(5):1051\u20137. https:\/\/doi.org\/10.1016\/s0006-291x(02)02038-7. PubMed PMID: 12207878.","journal-title":"Biochem Biophys Res Commun"},{"key":"445_CR41","doi-asserted-by":"publisher","unstructured":"Zdravkovic S, Wienke A, Pedersen NL, Marenberg ME, Yashin AI, De Faire U. Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. J Intern Med. 2002;252(3):247\u2009\u2013\u200954. https:\/\/doi.org\/10.1046\/j.1365-2796.2002.01029.x. PubMed PMID: 12270005.","DOI":"10.1046\/j.1365-2796.2002.01029.x"},{"issue":"22","key":"445_CR42","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1161\/circulationaha.119.044795","volume":"141","author":"P Hu","year":"2020","unstructured":"Hu P, Dharmayat KI, Stevens CAT, Sharabiani MTA, Jones RS, Watts GF, et al. Prevalence of Familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: A systematic review and Meta-Analysis. Circulation. 2020;141(22):1742\u201359. https:\/\/doi.org\/10.1161\/circulationaha.119.044795. Epub 20200529.","journal-title":"Circulation"},{"key":"445_CR43","doi-asserted-by":"publisher","unstructured":"Tada H, Hori M, Nomura A, Hosomichi K, Nohara A, Kawashiri MA et al. A catalog of the pathogenic mutations of LDL receptor gene in Japanese familial hypercholesterolemia. J Clin Lipidol. 2020;14(3):346\u2009\u2013\u200951.e9. Epub 20200324. https:\/\/doi.org\/10.1016\/j.jacl.2020.03.002. PubMed PMID: 32331935.","DOI":"10.1016\/j.jacl.2020.03"},{"key":"445_CR44","doi-asserted-by":"publisher","first-page":"e00181","DOI":"10.1016\/j.plabm.2020.e00181","volume":"22","author":"H Tada","year":"2020","unstructured":"Tada H, Shibayama J, Nishikawa T, Okada H, Nomura A, Usui S, et al. Prevalence, self-awareness, and LDL cholesterol levels among patients highly suspected as Familial hypercholesterolemia in a Japanese community. Pract Lab Med. 2020;22:e00181. PubMed PMID: 33134467; PubMed Central PMCID: PMC7585140.","journal-title":"Pract Lab Med"},{"issue":"16","key":"445_CR45","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","volume":"381","author":"IK Luirink","year":"2019","unstructured":"Luirink IK, Wiegman A, Kusters DM, Hof MH, Groothoff JW, de Groot E, et al. 20-Year Follow-up of Statins in children with Familial hypercholesterolemia. N Engl J Med. 2019;381(16):1547\u201356. https:\/\/doi.org\/10.1056\/NEJMoa1816454. PubMed PMID: 31618540.","journal-title":"N Engl J Med"},{"key":"445_CR46","doi-asserted-by":"publisher","unstructured":"Tada H, Takamura M, Kawashiri MA. Genomics of hypertriglyceridemia. Adv Clin Chem. 2020;97:141\u2009\u2013\u200969. Epub 20200214. https:\/\/doi.org\/10.1016\/bs.acc.2019.12.005. PubMed PMID: 32448433.","DOI":"10.1016\/bs.acc.2019.12"},{"issue":"9","key":"445_CR47","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1001\/jama.2017.0972","volume":"317","author":"AV Khera","year":"2017","unstructured":"Khera AV, Won HH, Peloso GM, O\u2019Dushlaine C, Liu D, Stitziel NO, et al. Association of rare and common variation in the lipoprotein lipase gene with coronary artery disease. JAMA. 2017;317(9):937\u201346. https:\/\/doi.org\/10.1001\/jama.2017.0972. PubMed PMID: 28267856; PubMed Central PMCID: PMC5664181.","journal-title":"JAMA"},{"issue":"7537","key":"445_CR48","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature13917","volume":"518","author":"R Do","year":"2015","unstructured":"Do R, Stitziel NO, Won HH, J\u00f8rgensen AB, Duga S, Angelica Merlini P, et al. Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. Nature. 2015;518(7537):102\u20136. https:\/\/doi.org\/10.1038\/nature13917. Epub 20141210.","journal-title":"Nature"},{"issue":"26","key":"445_CR49","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","volume":"361","author":"R Clarke","year":"2009","unstructured":"Clarke R, Peden JF, Hopewell JC, Kyriakou T, Goel A, Heath SC, et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med. 2009;361(26):2518\u201328. https:\/\/doi.org\/10.1056\/NEJMoa0902604. PubMed PMID: 20032323.","journal-title":"N Engl J Med"},{"key":"445_CR50","doi-asserted-by":"publisher","unstructured":"Torkamani A, Wineinger NE, Topol EJ. The personal and clinical utility of polygenic risk scores. Nat Rev Genet. 2018;19(9):581\u2009\u2013\u200990. https:\/\/doi.org\/10.1038\/s41576-018-0018-x. PubMed PMID: 29789686.","DOI":"10.1038\/s41576-018-0018-x"},{"issue":"9750","key":"445_CR51","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/s0140-6736(10)61267-6","volume":"376","author":"S Ripatti","year":"2010","unstructured":"Ripatti S, Tikkanen E, Orho-Melander M, Havulinna AS, Silander K, Sharma A, et al. A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet. 2010;376(9750):1393\u2013400. https:\/\/doi.org\/10.1016\/s0140-6736(10)61267-6. PubMed PMID: 20971364; PubMed Central PMCID: PMC2965351.","journal-title":"Lancet"},{"issue":"3","key":"445_CR52","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1161\/circresaha.117.312086","volume":"122","author":"P van der Harst","year":"2018","unstructured":"van der Harst P, Verweij N. Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease. Circ Res. 2018;122(3):433\u201343. https:\/\/doi.org\/10.1161\/circresaha.117.312086. Epub 20171206.","journal-title":"Circ Res"},{"issue":"9","key":"445_CR53","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/ng.3914","volume":"49","author":"D Klarin","year":"2017","unstructured":"Klarin D, Zhu QM, Emdin CA, Chaffin M, Horner S, McMillan BJ, et al. Genetic analysis in UK biobank links insulin resistance and transendothelial migration pathways to coronary artery disease. Nat Genet. 2017;49(9):1392\u20137. https:\/\/doi.org\/10.1038\/ng.3914. Epub 20170717.","journal-title":"Nat Genet"},{"issue":"7","key":"445_CR54","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.3874","volume":"49","author":"JMM Howson","year":"2017","unstructured":"Howson JMM, Zhao W, Barnes DR, Ho WK, Young R, Paul DS, et al. Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms. Nat Genet. 2017;49(7):1113\u20139. https:\/\/doi.org\/10.1038\/ng.3874. Epub 20170522.","journal-title":"Nat Genet"},{"issue":"10","key":"445_CR55","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1161\/strokeaha.114.006072","volume":"45","author":"H Tada","year":"2014","unstructured":"Tada H, Shiffman D, Smith JG, Sj\u00f6gren M, Lubitz SA, Ellinor PT, et al. Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke. Stroke. 2014;45(10):2856\u201362. https:\/\/doi.org\/10.1161\/strokeaha.114.006072. Epub 20140814.","journal-title":"Stroke"},{"issue":"9","key":"445_CR56","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","volume":"50","author":"AV Khera","year":"2018","unstructured":"Khera AV, Chaffin M, Aragam KG, Haas ME, Roselli C, Choi SH, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to Monogenic mutations. Nat Genet. 2018;50(9):1219\u201324. https:\/\/doi.org\/10.1038\/s41588-018-0183-z. Epub 20180813.","journal-title":"Nat Genet"},{"issue":"3","key":"445_CR57","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1161\/strokeaha.119.027520","volume":"51","author":"T Hachiya","year":"2020","unstructured":"Hachiya T, Hata J, Hirakawa Y, Yoshida D, Furuta Y, Kitazono T, et al. Genome-Wide polygenic score and the risk of ischemic stroke in a prospective cohort: the Hisayama study. Stroke. 2020;51(3):759\u201365. https:\/\/doi.org\/10.1161\/strokeaha.119.027520. Epub 20200131.","journal-title":"Stroke"},{"key":"445_CR58","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.116.024436","author":"P Natarajan","year":"2017","unstructured":"Natarajan P, Young R, Stitziel NO, Padmanabhan S, Baber U, Mehran R, et al. Circulation. 2017;135(22):2091\u2013101. https:\/\/doi.org\/10.1161\/circulationaha.116.024436. Epub 20170221. Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting."},{"issue":"24","key":"445_CR59","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1056\/NEJMoa1605086","volume":"375","author":"AV Khera","year":"2016","unstructured":"Khera AV, Emdin CA, Drake I, Natarajan P, Bick AG, Cook NR, et al. Genetic Risk, adherence to a healthy Lifestyle, and coronary disease. N Engl J Med. 2016;375(24):2349\u201358. Epub 20161113. doi: 10.1056\/NEJMoa1605086. PubMed PMID: 27959714; PubMed Central PMCID: PMC5338864.","journal-title":"N Engl J Med"},{"issue":"6","key":"445_CR60","doi-asserted-by":"publisher","first-page":"e0270292","DOI":"10.1371\/journal.pone.0270292","volume":"17","author":"J-R Li","year":"2022","unstructured":"Li J-R, Wang S-S, Chen C-S, Cheng C-L, Hung S-C, Lin C-H, et al. Conventional androgen deprivation therapy is associated with an increased risk of cardiovascular disease in advanced prostate cancer, a nationwide population-based study. PLoS ONE. 2022;17(6):e0270292.","journal-title":"PLoS ONE"},{"issue":"1","key":"445_CR61","doi-asserted-by":"publisher","first-page":"2988289","DOI":"10.1155\/2024\/2988289","volume":"2024","author":"CJ Wallis","year":"2024","unstructured":"Wallis CJ, Chen KC, Atkinson S, Boldt-Houle DM. Patient demographics and major adverse cardiovascular events after androgen deprivation therapy for prostate cancer. Adv Urol. 2024;2024(1):2988289.","journal-title":"Adv Urol"},{"issue":"5","key":"445_CR62","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1161\/CIRCULATIONAHA.115.012519","volume":"133","author":"N Bhatia","year":"2016","unstructured":"Bhatia N, Santos M, Jones LW, Beckman JA, Penson DF, Morgans AK, et al. Cardiovascular effects of androgen deprivation therapy for the treatment of prostate cancer: ABCDE steps to reduce cardiovascular disease in patients with prostate cancer. Circulation. 2016;133(5):537\u201341. PubMed PMID: 26831435; PubMed Central PMCID: PMC5029929.","journal-title":"Circulation"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-026-00445-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00445-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00445-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:00:53Z","timestamp":1770832853000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40959-026-00445-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["445"],"URL":"https:\/\/doi.org\/10.1186\/s40959-026-00445-7","relation":{"references":[{"id-type":"doi","id":"10.1161\/circulationaha.116.024436","asserted-by":"subject"}]},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Institutional Review Board of the Taichung Veterans General Hospital (IRB no. CE23119A). All participants completed a written inform consent form according to the Helsinki declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}